An animal study found that vitamin K2 as MK-7 boosts nitric oxide (NO) to improve NO-dependent endothelial function.
Photo © iStockphoto.com/anulla
An animal study recently published in Vascular Pharmacology1 found that vitamin K2 as MK-7 (MenaQ7 from Nattopharma; Edison, NJ) boosts nitric oxide (NO) to improve NO-dependent endothelial function. The mice, at early and late stages of atherosclerosis, taking low and high doses of MK-7, respectively, showed a similar degree of improvement in endothelium-dependent vasodilation and increase in plasma nitrate concentration.
“The study demonstrated that vitamin K2 - MK-7 improved NO-dependent endothelial function in mice, and the results showed that K2 - MK-7 provided a vaso-protective effect independently whether endothelial dysfunction was treated with vitamin K2 - MK-7 prior to or concurrently with the occurrence of atherosclerotic plaques,” explains Hogne Vik, NattoPharma’s chief medical officer, in a press release. “This contributes nicely to our already substantial body of research showing MenaQ7 is a cardio-protective nutrient, and reaffirms why the medical community is interested in ongoing study of this important nutrient for the betterment of global health.”
The study results are significant because they highlight a new pharmacological activity of vitamin K2 as MK-7, says Vik.
Cracking the code: Advancements in calcium absorption and nutritional understanding
July 23rd 2024Recent research conducted by ILSI U.S. and Canada – a global, nonprofit federation dedicated to advancing precompetitive research in the food, nutrition and health realms – and partially funded by Balchem, has shed light on how to improve predictions of Ca bioavailability across different food matrices.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.